Curation SCA10 ATXN10

Gene ATXN10
Disease SCA10
Inheritance AD
Score

12 + 2 = 14 / 18

Genetic + experimental = total
Classification
0
18
Refuted
Moderate
Definitive
Last Updated 08/12/2025
Pubs Reviewed 4
Publication Span 25.41 years
Publication Interval 25.41 years
Curator(s) Macayla Weiner, Laural Hiatt
Description

SCA10 is an autosomal dominant spinocerebellar ataxia characterized by cerebellar ataxia with variable seizures, caused by a large ATTCT pentanucleotide repeat expansion in intron 9 of ATXN10. Genetic evidence includes linkage to chromosome 22q13, segregation/haplotype evidence in SCA10 families, absence or low frequency of disease-associated haplotypes/expansions in controls, and repeat-size/structure variability. Experimental evidence supports ATXN10/Atx-10 as an important neuronal and cellular protein.

Genetic evidence

Total: 12

Category
Type
Citation
Score
Details
Singular Evidence
Probands
6

Six unrelated SCA10 families were analyzed (three Brazilian, two Mexican mapping families, and one early-onset Mexican patient), comprising 34 SCA10 expansion carriers and 20 relatives with cerebellar ataxia and variable seizures.

Collective Evidence
Allele
1

An inverse correlation has been observed between the expansion size and the age of onset (r2=0.34, P=0.018).

Collective Evidence
Segregation
1.5

A four-generation Mexican-American autosomal dominant SCA pedigree showed linkage to chromosome 22q13, with maximum two-point LOD score 4.30 at D22S928 and D22S1161 (θ=0) and informative haplotypes defining recombination events.

Statistics
Case-control data
6

SCA10 expanded chromosomes shared conserved intragenic/flanking haplotypes; 154 control chromosomes from Brazilian, Mexican, and Portuguese populations were analyzed for haplotype frequencies and showed low-frequency disease-associated flanking haplotypes.

Experimental evidence

Total: 2

Category
Type
Citation
Score
Details
Function
Regulatory impact
1

pmid:11017075 notes that the large intronic ATTCT expansion could affect ATXN10 transcription or post-transcriptional processing, but preliminary northern blot data showed no obvious SCA10 mRNA change in patient lymphoblastoid cells; pmid:38467784 provides review-level context that STR sequence composition can affect gene expression.

Functional Alteration
Patient cells
1

Patient lymphoblastoid cells were used for western blotting to exclude expanded polyglutamine proteins and for preliminary northern blot analysis showing no obvious SCA10 mRNA level change; disease-relevant patient-cell functional alteration was not demonstrated.

Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.